A Successful Treatment of Relapsed Primary CNS Lymphoma Patient with Intraventricular Rituximab Followed by High-Dose Chemotherapy with Autologous Stem Cell Rescue

The prognosis for patients with primary central nervous system (CNS) lymphoma (PCNSL) who relapse after the initial response is usually poor. A standard treatment for relapsed PCNSL has not yet been identified because of the heterogeneity of the therapies employed and the lack of large, prospective...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Hong, Sung Jin, Kim, Jin Seok, Chang, Jong Hee, Kim, Kyoung Min, Kim, Soo Jeong, Lee, Hye Won, Cheong, June-Won, Lee, Seung Tae, Min, Yoo Hong
Format: Artigo
Idioma:Inglês
Publicat: Yonsei University College of Medicine 2009
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2678705/
https://ncbi.nlm.nih.gov/pubmed/19430564
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3349/ymj.2009.50.2.280
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars